Breast cancer research : BCR

publication venue for

Associations of alcohol consumption with breast tissue composition.. 25. 2023
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers.. 25. 2023
Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression.. 24. 2022
Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses' health study.. 24. 2022
A genome-wide association study of mammographic texture variation.. 24. 2022
The association of age at menarche and adult height with mammographic density in the International Consortium of Mammographic Density.. 24. 2022
CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome.. 24. 2022
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci.. 24. 2022
Common variants in breast cancer risk loci predispose to distinct tumor subtypes.. 24. 2022
STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment.. 23. 2021
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.. 23. 2021
Adolescent and early adulthood inflammation-associated dietary patterns in relation to premenopausal mammographic density.. 23. 2021
Associations of reproductive breast cancer risk factors with breast tissue composition.. 23. 2021
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice.. 23. 2021
Immune phenotype of patients with stage IV metastatic inflammatory breast cancer.. 22. 2020
Hormonal determinants of mammographic density and density change.. 22. 2020
Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study.. 22. 2020
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies.. 22. 2020
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.. 21. 2019
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.. 21. 2019
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.. 21. 2019
Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype.. 21. 2019
Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies.. 21. 2019
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.. 21. 2019
Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.. 21. 2019
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study.. 20. 2018
Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.. 20. 2018
Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.. 20. 2018
Residential particulate matter and distance to roadways in relation to mammographic density: results from the Nurses' Health Studies.. 19. 2017
Alcohol consumption and breast tumor gene expression.. 19. 2017
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.. 19. 2017
AKT1^low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer.. 19. 2017
EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.. 19. 2017
Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.. 19. 2017
Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems.. 18. 2016
Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.. 18. 2016
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.. 18. 2016
Mammographic density and breast cancer risk: a mediation analysis.. 18. 2016
Adolescent fiber intake and mammographic breast density in premenopausal women.. 18. 2016
Clonal relationships between lobular carcinoma in situ and other breast malignancies.. 18. 2016
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.. 18. 2016
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas.. 18. 2016
The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.. 18. 2016
Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer.. 18. 2016
Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.. 18. 2016
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.. 18. 2016
High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.. 17. 2015
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer.. 17. 2015
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.. 17. 2015
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.. 17. 2015
Circulating tumor cells in newly diagnosed inflammatory breast cancer.. 17. 2015
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.. 16. 2014
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.. 16. 2014
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.. 16. 2014
Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.. 16. 2014
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.. 16. 2014
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.. 16. 2014
Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ.. 16. 2014
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer.. 16. 2014
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.. 15. 2013
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors.. 15. 2013
HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma.. 15. 2013
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype.. 15. 2013
Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging.. 15. 2013
Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions.. 14. 2012
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II.. 14. 2012
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.. 14. 2012
Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.. 13. 2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.. 13. 2011
Nondense mammographic area and risk of breast cancer.. 13. 2011
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.. 13. 2011
Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation.. 12. 2010
Mammary stem cells and cancer: roles of Wnt signaling in plain view.. 12. 2010
Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.. 12. 2010
Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer.. 12. 2010
The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.. 11. 2009
Immunohistochemical characterization of subtypes of male breast carcinoma.. 11. 2009
How much can improved molecular and pathologic discriminants change local therapy?. 10 Suppl 4. 2008
Breast cancer susceptibility loci and mammographic density.. 10. 2008
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.. 10. 2008
Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.. 9. 2007
Role of human HGFIN/nmb in breast cancer.. 9. 2007
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer.. 9. 2007
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.. 8. 2006
Single nucleotide polymorphisms and breast cancer: not yet a success story.. 8. 2006
Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study.. 7. 2005
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.. 7. 2005
Dose-dense adjuvant chemotherapy for primary breast cancer.. 7. 2005
Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study.. 6. 2004
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.. 6. 2003
Introduction to sessions on 'What can surgeons do for us (and we for them): radiology, pathology, molecular biology and local therapy'.. 10 Suppl 4. 2008
Mammographic density as a mediator for breast cancer risk: analytic approaches. 2012
The Third International Inflammatory Breast Cancer Conference. 2013
Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies. 2019
Molecular characterization and targeted therapeutic approaches in breast cancer. 2015
β1 and β4 integrins: from breast development to clinical practice. 2014
Mammographic density and risk of breast cancer by age and tumor characteristics. 2013
Delivery of gene silencing agents for breast cancer therapy. 2013
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. 2012
Local control by radiotherapy: is that all there is? 2008
New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists. 2004
Is there a role for Notch signalling in human breast cancer? 2003
The role of the ubiquitination-proteasome pathway in breast cancer: use of mouse models for analyzing ubiquitination processes. 2002
Predictive factor for the response to adjuvant therapy with emphasis in breast cancer. 2001
Wnt signaling in breast cancer: have we come full circle? 2001
Clinical aspects of sentinel node biopsy. 2001
The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer. 2000
Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. 2000

VIVO Weill Cornell Medical College

Breast cancer research : BCR Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)